Differential effect of phosphodiesterase inhibitors on IL-13 release from peripheral blood mononuclear cells

Clinical and Experimental Immunology

Volumn 126, Issue 3, 2001, Pages 384-389

  Yoshida, N ^a   Shimizu, Y ^a   Kitaichi, K ^a   Hiramatsu, K ^a   Takeuchi, M ^a   Ito, Y ^a   Kume, H ^a   Yamaki, K ^a   Suzuki, R ^b   Shibata, E ^a   Hasegawa, T ^a   Takagi, K ^a,b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Allergy; Asthma; cAMP; IL 13; Inhibitor; Phosphodiesterase

Indexed keywords

ADENYLATE CYCLASE; BUCLADESINE; CILOSTAZOL; CYCLIC AMP; FORSKOLIN; INTERLEUKIN 13; PHOSPHODIESTERASE INHIBITOR; PHYTOHEMAGGLUTININ; ROLIPRAM; THEOPHYLLINE;

ADULT; ALLERGIC ASTHMA; ALLERGIC DISEASE; ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; BLOOD; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL;

ADULT; ASTHMA; CYCLIC AMP; DEXAMETHASONE; FORSKOLIN; HUMANS; INTERLEUKIN-13; KINETICS; LEUKOCYTES, MONONUCLEAR; MALE; PHOSPHODIESTERASE INHIBITORS; PHYTOHEMAGGLUTININS; ROLIPRAM; TETRAZOLES; THEOPHYLLINE;

EID: 0035652585     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01646.x     Document Type: Article

References (41)

1. Immunological basis of antigen-induced airway hyperresponsiveness
2. TH2 and `TH2-like' cells in allergy and asthma: Pharmacological perspectives
3. IL-4 plays a dominant role in the differential development of Tho into Th1 and Th2 cells
4. Atopy and asthma: Genetic variants of IL-4 and IL-13 signalling
5. The IL-4 receptor: Signaling mechanisms and biological functions
6. Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function
7. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells
8. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells
9. Genetic variants of IL-13 signalling and human asthma and atopy
10. IL-13 expression at the sites of allergen challenge in patients with asthma
11. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma
12. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: More similarities than differences
13. Endobronchial secretion of interleukin-13 following local allergen challenge in atopic asthma: Relationship to interleukin-4 and eosinophil counts
14. Mite antigen-induced IL-4 and IL-13 production by basophils derived from atopic asthma patients
15. Environmental antigen-induced IL-13 responses are elevated among subjects with allergic rhinitis, are independent of IL-4, and are inhibited by endogenous IFN-gamma synthesis
16. Regulation of interleukin-13 by type 4 cyclic nucleotide phosphodiesterase (PDE) inhibitors in allergen-specific human T lymphocyte clones
17. Could isoenzyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma?
18. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes
19. Differential effect of phospho-diesterase 4 inhibitors on the proliferation of human peripheral blood mononuclear cells from normals and subjects with atopic dermatitis
20. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: A possible mechanism for cyclic AMP-agonist hyporesponsiveness
21. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition
22. Regulation of cAMP and cGMP signaling: New phosphodiesterases and new functions
23. + T-lymphocytes: Role in regulating proliferation and the biosynthesis of interleukin-2
24. Differential effects of phosphodiesterase type 4-specific inhibition on human autoreactive myelin-specific T cell clones
25. Cyclic AMP-elevating agents inhibit mite-antigen-induced IL-4 and IL-13 release from basophil-enriched leukocyte preparation
26. Cytokine production by phytohemagglutinin-stimulated human blood cells: Effects of corticos-teroids, T cell immunosuppressants and phosphodiesterase IV inhibitors
27. Hydrocortisone inhibition of human interleukin-4
28. Glucocorticoids suppressed production and gene expression of interleukin-5 by peripheral blood mononuclear cells in atopic patients and normal subjects
29. Interleukin-4 gene expression in activated human T lymphocytes is regulated by the cyclic adenosine monophosphate-dependent signaling pathway
30. Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes
31. Effects of nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors on antigen-induced cytokine gene expression in peripheral blood mononuclear cells
32. Involvement of cyclic AMP in the effects of phosphodiesterase IV inhibitors on arachidonate release from mononuclear cells
33. Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells
34. Modulation of Th1- and Th2-like cytokine production from mitogen-stimulated human peripheral blood mononuclear cells by phosphodiesterase inhibitors
35. Cyclic AMP activates p38 mitogen-activated protein kinase in Th2 cells: Phosphorylation of GATA-3 and stimulation of Th2 cytokine gene expression
36. IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression
37. The role of IL-13 in IgE synthesis by allergic asthma patients
38. Differential modulation of interleukin-4 and interleukin-13 secretion from human peripheral blood mononuclear cells
39. In vitro interleukin-13 production by peripheral blood in patients with newly diagnosed insulin-dependent diabetes mellitus and their first degree relatives
40. Interleukin-13: Central mediator of allergic asthma
41. Requirement for IL-13 independently of IL-4 in experimental asthma